When we used multifactorial analysis to examine the relation between the presence of late potentials and the other variables, the best predictor was the patency of the infarct-related artery followed by the administration of intravenous streptokinase and an inferior site of the infarct. The effect of the patency of the infarctrelated artery was independent of that of streptokinase. The influence of age, apparent initially, became unimportant when these variables were taken into account.
Discussion
Most clinical studies of ventricular late potentials have examined their ability to identify patients at risk of ventricular arrhythmias after acute myocardial infarction. We showed that ventricular late potentials were less common in patients with acute myocardial infarction treated with intravenous streptokinase than in those treated conservatively. Our study also showed that the absence of ventricular late potentials after acute myocardial infarction is a good, non-invasive predictor of the patency of the infarct-related artery. This may be valuable information because thrombolytic treatment is now widely used and the absence of ventricular late potentials may help to identify those patients who will benefit most from coronary arteriography and perhaps further invasive treatment.
Our study showed that the patency of the infarct-related artery exerts an independent effect on the presence of late potentials. Our data, in accord with those of others,9 1819 do not suggest that the presence or absence of ventricular late potentials correlate with left ventricular ejection fraction. Successful thrombolytic treatment results in an electrically more stable myocardium2"22 and
Braunwald has suggested that a patent, bloodfilled, infarct-related artery and vascular bed may provide a scaffolding that limits expansion of the necrotic myocardium. 23 We further propose that the lower incidence of ventricular late potentials in patients treated with intravenous streptokinase may be related to the reduction in mortality in this group compared with a conservatively treated group.
Gang et al found that the occurrence of ventricular late potentials in acute myocardial infarction was significantly less after successful thrombolytic treatment with tissue plasminogen activator (5%) than after conservative treatment (230`). ' 
